ask="2.70"
ask_size="200"
average_daily_volume="581011"
bid="2.58"
bid_size="800"
book_value="3.56"
change="+0.07"
change_from_200_day_moving_average="-2.31"
change_from_50_day_moving_average="0.33"
change_from_52_week_high="-6.73"
change_From_52_week_low="0.62"
change_in_percent="+2.75%"
close="2.62"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.03"
ebitda="-31.76M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.45"
eps_estimate_next_year="-1.33"
ex_dividend_date="N/A"
float_shares="8489000"
high="2.65"
high_52_weeks="9.35"
last_trade_date="2/16/2017"
last_trade_price="2.62"
last_trade_size="4790"
last_trade_time="4:00pm"
low="2.53"
low_52_weeks="2.00"
market_capitalization="41.02M"
moving_average_200_day="4.93"
moving_average_50_day="2.29"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.63"
open="2.56"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-46.82%"
percent_change_from_50_day_moving_average="+14.29%"
percent_change_from_52_week_high="-71.98%"
percent_change_from_52_week_low="+31.00%"
previous_close="2.55"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.72"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15656000"
short_ratio="0.64"
stock_exchange="NGM"
symbol="NVLS"
volume="336982"
weeks_range_52="2.00 - 9.35"
